DWA
Dorsey Wright & Associates’s Novo Nordisk NVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-62,128
| Closed | -$7.4M | – | 140 |
|
|
2024
Q3 | $7.4M | Buy |
62,128
+7,543
| +14% | +$898K | 1.75% | 9 |
|
|
2024
Q2 | $7.79M | Sell |
54,585
-1,850
| -3% | -$264K | 2.02% | 4 |
|
|
2024
Q1 | $7.25M | Sell |
56,435
-3,334
| -6% | -$428K | 1.89% | 6 |
|
|
2023
Q4 | $6.18M | Sell |
59,769
-4,644
| -7% | -$480K | 1.88% | 5 |
|
|
2023
Q3 | $5.86M | Buy |
64,413
+30,137
| +88% | +$2.74M | 1.82% | 6 |
|
|
2023
Q2 | $5.55M | Sell |
34,276
-3,444
| -9% | -$557K | 1.67% | 8 |
|
|
2023
Q1 | $6M | Sell |
37,720
-2,512
| -6% | -$400K | 1.82% | 5 |
|
|
2022
Q4 | $5.44M | Buy |
+40,232
| New | +$5.44M | 1.59% | 8 |
|
|
2022
Q2 | $4.98M | Sell |
44,706
-5,318
| -11% | -$593K | 1.46% | 14 |
|
|
2022
Q1 | $5.56M | Sell |
50,024
-1,503
| -3% | -$167K | 1.29% | 16 |
|
|
2021
Q4 | $5.77M | Buy |
51,527
+1,013
| +2% | +$113K | 1.19% | 23 |
|
|
2021
Q3 | $4.85M | Buy |
+50,514
| New | +$4.85M | 1.06% | 31 |
|
|
2021
Q1 | – | Sell |
-59,319
| Closed | -$4.14M | – | 346 |
|
|
2020
Q4 | $4.14M | Sell |
59,319
-821
| -1% | -$57.3K | 0.61% | 37 |
|
|
2020
Q3 | $4.18M | Buy |
60,140
+866
| +1% | +$60.1K | 0.75% | 33 |
|
|
2020
Q2 | $3.89M | Sell |
59,274
-4,865
| -8% | -$319K | 0.79% | 28 |
|
|
2020
Q1 | $3.86M | Buy |
64,139
+17,939
| +39% | +$1.08M | 1.46% | 17 |
|
|
2019
Q4 | $2.67M | Buy |
+46,200
| New | +$2.67M | 0.88% | 41 |
|
|
2013
Q3 | – | Sell |
-894
| Closed | -$139K | – | 121 |
|
|
2013
Q2 | $139K | Buy |
+894
| New | +$139K | 0.02% | 86 |
|